Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abiraterone acetate plus prednisone in post-docetaxel mCRPC
NCT00638690Phase 3Completed
- Sponsor
- Cougar Biotechnology
- Start
- May 2008
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of abiraterone acetate in metastatic castration-resistant prostate cancer (mCRPC), sponsored by Cougar Biotechnology. Started May 2008; status: completed.
02
Drugs
abiraterone acetate
03
Conditions
metastatic castration-resistant prostate cancer (mCRPC)
Beyond the preview
Go deeper on NCT00638690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00638690.